“The entire experience of participating in the clinical trial has been exceptional. The team at Re:Cognition Health genuinely prioritises the wellbeing of their patients. Their understanding and willingness to assist in every possible way have made a significant difference. I feel incredibly fortunate to have been part of this trial and to regain a new lease of life.”
Mike was diagnosed with Alzheimer’s through Re:Cognition Health just over two years ago and was enrolled in a clinical trial testing Donanemab. He learned about clinical trials through his neighbour, who had also been diagnosed with Alzheimer’s and was participating in a study.
Mike initially experienced symptoms of forgetfulness, difficulty recalling names of people or certain objects, and trouble navigating. He often felt like he wasn’t always “in the room.” He became very confused about who he was, what he was doing, and where he was going. He couldn’t figure out how to get back from places where he had spent 40 years driving around.
After completing the clinical trial, which involved infusions every 4 weeks at Re:Cognition Health’s London clinic, Mike feels like he has his life back. His confusion has gone and he is now quite comfortable driving somewhere, finding the place, and then finding his way home. While he struggles with night driving, he recently drove 40 minutes in the dark on his own, which was a proud moment for him.
Mike still occasionally struggles with forgetting words or names, but this is very minor and doesn’t affect his daily life. He has no problem telling people that he has Alzheimer’s, and people are always happy to help and support him. He believes it’s nothing to be ashamed of. He understands that Alzheimer’s is progressive and the condition deteriorates over time, eroding the quality of life. However, he feels like he has a new lease of life with renewed hope and confidence for the future.
Mike has always been fit and active and he continues to enjoy exercise daily with a 45 minute walk every morning and sometimes does another in the evening. He swims six days a week (taking Sundays off) and works out at the gym. Living independently, he finds it easy to avoid feeling morose and sorry for himself. Instead, he feels very lucky, always has a smile on his face, and is happy to have been put on the trial which has improved his health and outlook.
Mike tells his story to the Telegraph: https://www.telegraph.co.uk/health-fitness/conditions/dementia/alzheimers-drug-donanemab-changed-life/